Discover 3,494 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,494
Brain Imaging Biomarkers for Response to Spinal Cord Stimulation in Patients With Chronic Low Back Pain
for
Chronic Low-back Pain
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 21+
Code: NCT04658628
Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Los Angeles CA, Fountain Valley CA, Oxnard CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Van Nuys CA, Palm Springs CA, Bakersfield CA,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation
for
Non-small Cell Lung Cancer
Location: Los Angeles CA, Fairfax VA, New York NY, Boston MA
Sponsor: RedCloud Bio
Sex: All
Age: 18+
Code: NCT05519293
Phase 1, Phase 2, Recruiting
Losartan + Sunitinib in Treatment of Osteosarcoma
for
Osteosarcoma
Location: Los Angeles CA, Aurora CO, Atlanta GA
Sponsor: University of Colorado, Denver
Sex: All
Age: 10+
Code: NCT03900793
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Regeneron AA Multicenter (Dupilumab)
for
Alopecia Areata
Location: Irvine CA, Rochester NY, New York NY
Sponsor: Emma Guttman
Sex: All
Age: 18+
Code: NCT05551793
Phase 2, Recruiting
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Angeles CA, Seattle WA, Houston TX, Madison WI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06625593
Phase 1, Recruiting
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Los Angeles CA, Duarte CA, Denver CO, Houston TX,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05482893
Phase 1, Phase 2, Recruiting
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
for
Pancreatic Cancer
Location: Los Angeles CA
Sponsor: Anova Innovation Limited
Sex: All
Age: 18+
Code: NCT07444541
Phase 1, Phase 2, Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
for
Multiple Myeloma
Location: Los Angeles CA, Orange CA, Denver CO, Houston TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05828511
Phase 1, Phase 2, Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Los Angeles CA, Houston TX, Grand Rapids MI, Toledo OH,
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Sex: All
Age: 18+
Code: NCT06095583
Phase 3, Recruiting
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Location: Los Angeles CA, Fullerton CA, Tyler TX, Minneapolis MN,
Sponsor: TORL Biotherapeutics, LLC
Sex: All
Age: 18+
Code: NCT05103683
Phase 1, Recruiting
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
for
Alagille Syndrome,
Location: Los Angeles CA, Salt Lake City UT, Portland OR,
Sponsor: Mirum Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT06193928
Recruiting
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
for
Urothelial Carcinoma, Muscle-invasive Bladder Cancer
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT06682728
Phase 2, Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Los Angeles CA, Murrieta CA, Glendale CA, Duarte CA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase 1, Phase 2, Recruiting
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
for
Carcinoma, Non-small-Cell Lung
Location: Orange CA, La Jolla CA, Stanford CA, Seattle WA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05498428
Phase 2, Recruiting
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
for
Advanced Pancreatic Adenocarcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06454383
Phase 1, Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Glendale CA, Orange CA, Redlands CA, Oceanside CA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 0+
Code: NCT06480383
Phase 2, Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Santa Monica CA, Santa Rosa CA, Albuquerque NM,